Compare Centene Corp (CNC) vs First Solar, Inc. (FSLR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Centene Corp vs First Solar, Inc. — how do they compare? Centene Corp trades at $66.78 (market cap $33.93B), while First Solar, Inc. trades at $221.08 (market cap $23.70B). The key difference: Centene Corp is the larger of the two by market cap, and Centene Corp is trading nearer its 52-week high, First Solar, Inc. nearer its low. Which is the better fit depends on your goals.
| CNC | FSLR | |
|---|---|---|
Market Cap | $33.93B | $23.70B |
Sector | Health | Technology |
52-Week High | $68.72 | $318.30 |
52-Week Low | $25.21 | $166.82 |
Enterprise Value | $26.56B | $21.86B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Centene Corporation (CNC) trades at $68.29, up 1.4% with strong technical momentum and bullish moving average signals. The stock shows impressive 66% YTD gains, supported by recent contract renewals and margin recovery initiatives. Despite negative 2025 net income of -$6.67B, valuation metrics remain attractive with P/E of 8.06 and P/S of 0.17. Analyst consensus is strongly bullish with 61% buy ratings and $66.07 price target.
Centene presents a compelling value opportunity with low valuation multiples and strong operational cash flow of $5.09B. Key risks include ongoing margin pressure and Medicaid contract dependency. The company's AI-driven cost controls and recent Illinois Medicaid renewal provide catalysts for earnings recovery, though healthcare regulatory changes remain a concern for long-term stability.
First Solar (FSLR) trades at $221.03, down 2.98% on the day, amid bearish technical signals and multiple class-action lawsuit announcements. The stock shows strong fundamentals with a P/E of 14.28, net income margin of 30.73%, and robust cash flow growth, but recent earnings misses and legal overhangs weigh on sentiment. Analyst consensus remains bullish with a $275.17 price target, highlighting a disconnect between near-term headwinds and long-term growth prospects in the solar energy sector.
The outlook for FSLR balances solid financial health and analyst optimism against significant litigation risks and technical weakness. Investment opportunity lies in its profitability and sector tailwinds, but investors face volatility from legal proceedings and market sentiment pressures. Careful monitoring of lawsuit developments and quarterly earnings is essential for navigating the stock's near-term trajectory.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Centene Corp
Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of September 2021, mostly in Medicaid (68% of membership), the individual exchanges (10%), Medicare Advantage (6%), and the balance in Tricare (West region), correctional facility, and international plans. The company also serves 4 million users through the Medicare Part D pharmaceutical program.
Read more on CNC →About First Solar, Inc.
First Solar designs and manufactures solar photovoltaic panels, modules, and systems for use in utility-scale development projects. The company's solar modules use cadmium telluride to convert sunlight into electricity. This is commonly called thin-film technology. First Solar is the world's largest thin-film solar module manufacturer. It has production lines in Vietnam, Malaysia, the United States, and a new factory under construction in India.
Read more on FSLR →
